Targeting oxidative stress for neuroprotection

Antioxidants and Redox Signaling

Volumn 11, Issue 3, 2009, Pages 421-423

  Linseman, Daniel A ^a  

^a UNIVERSITY OF DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ASCORBIC ACID; CATECHIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; GLUTATHIONE; NUTRACEUTICAL; ORGANOSULFUR DERIVATIVE; PEPTIDE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; POLYPHENOL DERIVATIVE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRANSCRIPTION FACTOR NRF2; UBIQUINONE; ANTIOXIDANT; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; AUTOPHAGY; CATALYSIS; CELL ORGANELLE; CLINICAL TRIAL; DEGENERATIVE DISEASE; EDITORIAL; ENZYME ACTIVITY; HUMAN; HUNTINGTON CHOREA; MITOCHONDRION; NEUROPROTECTION; NITROSYLATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING;

ANTIOXIDANTS; HUMANS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS;

EID: 58849103904     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2236     Document Type: Editorial

References (19)

1. Beal MF. Mitochondria and neurodegeneration. Novartis Found Symp 287: 183-192, 2007.
2. Calkins MJ, Johnson DA, Townsend JA, Vargas MR, Dowell JA, Williamson TP, Kraft AD, Lee J-M, Li J, and Johnson JA. The Nrf2/ARE pathway as a potential therapeutic target in neurodegenerative disease. Antioxid Redox Signaling 11: 497-508, 2009.
3. Casetta I, Govoni V, and Granieri E. Oxidative stress, antioxidants and neurodegenerative diseases. Curr Pharm Des 11: 2033-2052, 2005.
4. Clark J and Simon DK. Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease. Antioxid Redox Signaling 11: 509-528, 2009.
5. Esteves AR, Arduíno DM, Swerdlow RH, Oliveira CR, and Cardoso SM. Oxidative stress involvement in α-synuclein oligomerization in Parkinson's disease cybrids. Antioxid Redox Signaling 11: 439-448, 2009.
6. Ethell DW and Fei Q. Parkinson-linked genes and toxins that affect neuronal cell death through the Bcl-2 family. Antioxid Redox Signaling 11: 529-540, 2009.
7. Golden TR and Patel M. Catalytic antioxidants and neurodegeneration. Antioxid Redox Signaling 11: 555-569, 2009.
8. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 97: 1634-1658, 2006.
9. Hensley K, Mhatre M, Mou S, Pye QN, Stewart C, West M, and Williamson KS. On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Antioxid Redox Signaling 8: 2075-2087, 2006.
10. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, and Murphy MP. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276: 4588-4596, 2001.
11. Khanna S, Park H-A, Sen CK, Golakoti T, Sengupta K, Venkateswarlu S, and Roy S. Neuroprotective and antiinflammatory properties of a novel demethylated curcuminoid. Antioxid Redox Signaling 11: 449-468, 2009.
12. Knott AB and Bossy-Wetzel E. Nitric oxide in health and disease of the nervous system. Antioxid Redox Signaling 11: 541-553, 2009.
13. Pivtoraiko VN, Stone SL, Roth KA, and Shacka JJ. Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death. Antioxid Redox Signaling 11: 481-496, 2009.
14. Schroeder EK, Kelsey NA, Doyle J, Breed E, Bouchard RJ, Loucks FA, Harbison RA, and Linseman DA. Green tea epigallocatechin 3-gallate accumulates in mitochondria and displays a selective antiapoptotic effect against inducers of mitochondrial oxidative stress in neurons. Antioxid Redox Signaling 11: 469-480, 2009.
15. Smith RA, Porteous CM, Coulter CV, and Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem 263: 709-716, 1999.
16. Tansey MG, Frank-Cannon TC, McCoy MK, Lee JK, Martinez TN, McAlpine FE, Ruhn KA, and Tran TA. Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy? Front Biosci 13: 709-717, 2008.
17. Vincent AM, Kato K, McLean LL, Soules ME, and Feldman EL. Sensory neurons and Schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxid Redox Signaling 11: 425-438, 2009.
18. von Bernhardi R. Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 12: 215-232, 2007.
19. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, and Szeto HH. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279: 34682-34690, 2004.